IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
IMMUTEP Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Oct 24, 2025
$3.17−0.03 (-0.94%)
Close on Oct 19, 2026
Ownership
Who owns Immutep's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Marc Voigt | See Remarks, Director | 85,700 | Apr 13, 2026 |
| Deanne Diem Miller | Chief Operating Officer | 2,867,305 | Apr 13, 2026 |
| Christian Mueller | Chief Development Officer | 3,774,048 | Apr 1, 2026 |
| Stephan Karel Gerard Winckels | Chief Medical Officer | 92,935 | Apr 1, 2026 |
| Elisabeth Amanda Boyce | Director | 423,288 | Apr 16, 2026 |
| Pete A. Meyers | Director | 4,052,173 | Apr 7, 2026 |
| Frederic Joseph Daniel Triebel | Director | 170,610 | Apr 1, 2026 |
| Russell J. Howard | Director | 1,717,977 | Apr 1, 2026 |